HBAN

Huntington Bancshares

$18.01

+0.67%
Jul 7, 2026
Bobby Quantitative Model
Huntington Bancshares is a regional U.S. bank with over $285 billion in assets, offering consumer deposit and lending services along with commercial banking, payments, investment management, and capital markets solutions. As a top-20 U.S. regional bank, it differentiates itself through a strong Midwest footprint and a diversified fee-income stream from cards, trust, and leasing. The current investor narrative centers on net interest margin stabilization and expense discipline, with recent quarterly results showing revenue growth of 5.8% year-over-year and improving profitability. Debate remains around the trajectory of loan growth and deposit costs in a shifting rate environment.

People also watch

PNC Financial Services

PNC Financial Services

PNC

Analysis
Truist Financial

Truist Financial

TFC

Analysis
Fifth Third Bancorp

Fifth Third Bancorp

FITB

Analysis
M&T Bank

M&T Bank

MTB

Analysis
Citizens Financial Group

Citizens Financial Group

CFG

Analysis

HBAN 12-Month Price Forecast

Historical Price
Current Price $18.01
Average Target $18.01
High Target $20.7115
Low Target $15.3085

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Huntington Bancshares's 12-month outlook, with a consensus price target around $23.41 and implied upside of +30.0% versus the current price.

Average Target

$23.41

2 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

2

covering this stock

Price Range

$14 - $23

Analyst target range

Buy
0 (0%)
Hold
1 (50%)
Sell
1 (50%)

Only 2 analysts cover HBAN, which is limited for a regional bank of its size. The consensus recommendation leans bullish, with ratings including Buy from DA Davidson and Truist, Overweight from Morgan Stanley and JP Morgan, and Market Perform from Keefe, Bruyette & Woods. The average target price is not explicitly provided, but based on the estimated EPS of $1.73 and forward P/E of 9.38x, the implied target is approximately $16.23, which is 9.1% below the current price of $17.86. This suggests a neutral-to-bearish consensus, though the limited coverage reduces confidence. The estimated EPS range is $1.71 to $1.74, and revenue estimates range from $8.14 billion to $8.25 billion, indicating a narrow spread and relatively high conviction. The lack of a formal average target price and the small number of analysts mean that investors should rely more on fundamental analysis. The limited coverage implies that HBAN may be less efficiently priced, offering potential opportunities for active investors.

Drowning in data?

Find the real signal!

HBAN Technical Analysis

HBAN is in a recovery phase after a significant downtrend, with the 1-year price change of +2.64% lagging the S&P 500's +19.1% gain. The stock currently trades at $17.86, approximately 91.8% of its 52-week range ($14.89–$19.46), indicating it has recovered from the lows but remains below the highs. This positioning suggests the stock is in a rebuilding phase, with potential for further upside if momentum sustains, but still below prior peaks. Short-term momentum is strong: the 1-month price change is +10.04% and the 3-month change is +13.11%, both outpacing the S&P 500's respective returns of -1.25% and +13.56%. This acceleration from the longer-term trend signals a potential trend reversal, as the stock has broken above its 50-day moving average and is approaching resistance near the 52-week high. The relative strength index (RSI) is not provided, but the volume data is missing; however, the short ratio of 3.46 suggests moderate bearish sentiment. Key support lies at the 52-week low of $14.89, while resistance is at $19.46. A breakout above $19.46 would signal a resumption of the uptrend, targeting the next psychological level near $20. A breakdown below $14.89 would indicate renewed weakness. With a beta of 0.95, HBAN is slightly less volatile than the market, meaning it may underperform in strong rallies but also hold up better in downturns.

Beta

0.95

0.95x market volatility

Max Drawdown

-22.1%

Largest decline past year

52-Week Range

$15-$19

Price range past year

Annual Return

+2.7%

Cumulative gain past year

PeriodHBAN ReturnS&P 500
1m+9.0%+1.4%
3m+10.2%+10.6%
6m-2.5%+8.4%
1y+2.7%+20.5%
ytd+3.0%+9.7%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

HBAN Fundamental Analysis

Revenue has been steadily growing, with the most recent quarter (Q4 2025) reporting $3.247 billion, up 5.8% year-over-year from $3.069 billion in Q4 2024. The multi-quarter trend shows acceleration: Q1 2025 revenue was $2.983 billion, Q2 $3.027 billion, Q3 $3.228 billion, and Q4 $3.247 billion, indicating a consistent upward trajectory. Key revenue drivers include net interest income (interest income of $2.665 billion in Q4 2025) and fee income from cards ($162 million), trust services ($101 million), and service charges ($68 million). The growth is supported by loan expansion and higher yields, though deposit costs remain a headwind. Net income for Q4 2025 was $519 million, with a net margin of 15.98%, up from 17.27% in Q4 2024. Gross margin improved to 63.17% from 60.18% a year ago, reflecting better net interest margin and fee income. Operating margin was 19.43%, slightly below the 21.80% in Q4 2024, due to higher non-interest expenses. The company is profitable with a trailing EPS of $0.31 per share (diluted $0.30), and the payout ratio is 49.1%, indicating a sustainable dividend. The balance sheet shows a debt-to-equity ratio of 0.76, which is moderate for a regional bank. Free cash flow (TTM) is $2.265 billion, providing ample coverage for dividends and capital expenditures. The current ratio of 0.19 is low, typical for banks, but the cash position is strong at $13.495 billion. ROE is 9.08%, reflecting decent profitability, while ROA is 0.90%, in line with industry averages. The company generates sufficient operating cash flow ($829 million in Q4 2025) to fund internal growth and dividends.

Quarterly Revenue

$3.2B

2025-12

Revenue YoY Growth

+0.05%

YoY Comparison

Gross Margin

+0.63%

Latest Quarter

Free Cash Flow

$2.3B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Insurance Revenue
Other Revenue
Cards And Payment Processing Revenue
Leasing Revenue
Service Charges Revenue
Trust And Investment Management Services Revenue

Open an Account, get $2 TSLA now!

Valuation Analysis: Is HBAN Overvalued?

Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 12.30x, while the forward P/E is 9.38x, implying the market expects earnings growth. The gap between trailing and forward P/E suggests analysts anticipate a 24% increase in earnings per share over the next year. Compared to the industry average (banks - regional), HBAN's trailing P/E of 12.30x is below the sector median of approximately 15x, indicating a discount of about 18%. However, the forward P/E of 9.38x is also below the industry forward average of ~11x, suggesting the discount persists. This discount may be justified by HBAN's slightly lower ROE (9.08%) versus peers, but its revenue growth of 5.8% is competitive. Historically, HBAN's trailing P/E has ranged from 6.7x (early 2023) to 18.9x (late 2023). The current 12.30x is near the middle of this range, suggesting fair valuation relative to its own history. The P/B ratio of 1.05x is below the 5-year average of ~1.2x, indicating the stock is trading at a discount to book value, which could be attractive for value investors. The PEG ratio of 0.90x suggests the stock is undervalued relative to its growth rate.

PE

12.3x

Latest Quarter

vs. Historical

High-End

5-Year PE Range -268x~19x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

12.3x

Enterprise Value Multiple